DRUG PROTEIN BINDING AND THE NEPHROTIC SYNDROMEGUGLER R; AZARNOFF DL.1976; CLIN. PHARMACOKINET.; NETHERL.; DA. 1976; VOL. 1; NO 1; PP. 25-35; BIBL. 1 P. 1/2Article

A RAPID GAS CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF CHLOROPHENOXYISOBUTYRIC ACID IN PLASMA AND URINEGUGLER R; JENSEN C.1976; J. CHROMATOGR.; NETHERL.; DA. 1976; VOL. 117; NO 1; PP. 175-179; BIBL. 20 REF.Article

H₂-antagonists and alcohol : do they interact ?GUGLER, R.Drug safety. 1994, Vol 10, Num 4, pp 271-280, issn 0114-5916Article

CLOFIBRATE KINETICS AFTER SINGLE AND MULTIPLE DOSESGUGLER R; HARTLAPP J.1978; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1978; VOL. 24; NO 4; PP. 432-438; BIBL. 15 REF.Article

BIOVERFUEGBARKEIT VON CLOFIBRAT. VERGLEICHENDE UNTERSUCHUNGEN ZWISCHEN REGELAN UND BIOSCLERAN. = BIODISPONIBILITE DU CLOFIBRATE. ETUDE COMPARATIVE DU REGELAN ET DU BIOSCLERANGUGLER R; JENSEN CJ.1977; MUENCH. MED. WOCHR.; DTSCH.; DA. 1977; VOL. 119; NO 35; PP. 1109-1110; BIBL. 5 REF.Article

SENSITIVE GAS-LIQUID CHROMATOGRAPHIC METHOD FOR DETERMINATION OF VALPROIC ACID IN BIOLOGICAL FLUIDS.JENSEN CJ; GUGLER R.1977; J. CHROMATOGR.; NETHERL.; DA. 1977; VOL. 137; NO 1; PP. 188-193; BIBL. 21 REF.Article

SINGLE AND MULTIPLE DOSE PHARMACOKINETICS OF PINDOLOL.GUGLER R; BODEM G.1978; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1978; VOL. 13; NO 1; PP. 13-16; BIBL. 17 REF.Article

PREDICTION OF BIOAVAILABILITY FOR DRUGS WITH A HIGH FIRST-PASS EFFECT USING ORAL CLEARANCE DATASOMOGYI A; EICHELBAUM M; GUGLER R et al.1982; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1982; VOL. 22; NO 1; PP. 85-90; BIBL. 26 REF.Article

GASTRIC ACID INHIBITION AND OXMETIDINE KINETIES IN DUODENAL ULCERGUGLER R; ROHNER HG; SOMOGYI AA et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 31; NO 4; PP. 501-508; BIBL. 12 REF.Article

MALIGNANT PHEOCHROMOCYTOMA. EFFECT OF ORAL ALPHA -METHYL-P-TYROSINE UPON CATECHOLAMINE METABOLISMHENGSTAMANN JH; GUGLER R; DENGLER HJ et al.1979; KLIN. WSCHR.; DEU; DA. 1979; VOL. 57; NO 7; PP. 351-355; ABS. GER; BIBL. 16 REF.Article

VALPROINSAEURE IN DER BEHANDLUNG DER EPILEPSIEN UNTER BESONDERER BERUECHSICHTIGUNG DES SERUMSPIEGELS. = ACIDE VALPROIQUE DANS LE TRAITEMENT DE L'EPILEPSIE AVEC ETUDE PARTICULIERE DU DOSAGE DANS LE SERUM.FROSCHER W; SCHULZ HU; GUGLER R et al.1978; FORTSCHR. NEUROL. PSYCHIATR. GRENZGEB.; DEU; DA. 1978; VOL. 46; NO 6; PP. 327-341; ABS. ANGL.; BIBL. 4 P.Article

DIPHENYLHYDANTOIN: CORRELATION BETWEEN PROTEIN BINDING AND ALBUMIN CONCENTRATION = CORRELATION ENTRE LA LIAISON DIPHENYLHYDANTOINE-PROTEINES ET LA CONCENTRATION DU PLASMA EN ALBUMINEGUGLER R; AZARNOFF DL; SHOEMAN DW et al.1975; KLIN. WSCHR.; DTSCH.; DA. 1975; VOL. 53; NO 9; PP. 445-446; ABS. ALLEM.; BIBL. 13REF.Article

EFFECT OF PORTACAVAL SHUNT ON THE DISPOSITION OF DRUGS WITH AND WITHOUT FIRST-PASS EFFECT. = EFFET D'UN SHUNT PORTOCAVE SUR LE SORT DES MEDICAMENTS AVEC ET SANS EFFET DE PREMIER PASSAGEGUGLER R; LAIN P; AZARNOFF DL et al.1975; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1975; VOL. 195; NO 3; PP. 416-423; BIBL. 19 REF.Article

PHARMACOKINETICS OF A NEW BETA -ADRENOCEPTOR BLOCKING AGENT, LF 17-895, IN MANGUGLER R; KREIS L; DENGLER HJ et al.1975; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1975; VOL. 25; NO 7; PP. 1067-1072; ABS. ALLEM.; BIBL. 14 REF.Article

ALTERED DISPOSITION AND AVAILABILITY OF CIMETIDINE IN LIVER CIRRHOTIC PATIENTSGUGLER R; MULLER LIEBENAU B; SOMOGYI A et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 14; NO 3; PP. 421-430; BIBL. 26 REF.Article

IMPAIRED CIMETIDINE ABSORPTION DUE TO ANTACIDS AND METOCLOPRAMIDEGUGLER R; BRAND M; SOMOGYI A et al.1981; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1981; VOL. 20; NO 3; PP. 225-228; BIBL. 19 REF.Article

INFLUENCE OF PHENOBARBITAL TREATMENT ON CIMETIDINE KINETICSSOMOGYI A; THIELSCHER S; GUGLER R et al.1981; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1981; VOL. 19; NO 5; PP. 343-347; BIBL. 17 REF.Article

EPILEPSIE-THERAPIE MIT VALPROINSAEURE: KORRELATION VON NEBENWIRKUNGEN UND VALPROINSAEURE-SERUMSPIEGEL = TRAITEMENT DE L'EPILEPSIE PAR L'ACIDE VALPROIQUE. CORRELATION DES EFFETS SECONDAIRES ET DU TAUX SERIQUE D'ACIDE VALPROIQUEFROESCHER W; SCHULZ HU; GUGLER R et al.1979; FORTSCHR. D. MED.; DEU; DA. 1979; VOL. 97; NO 34; PP. 1464-1466; (3 P.); ABS. ENG; BIBL. 15 REF.Article

EFFECT OF IN VIVO ELEVATION OF FREE FATTY ACIDS ON PROTEIN BINDING OF DRUGS = EFFET DE L'ACCROISSEMENT IN VIVO DES ACIDES GRAS LIBRES SUR LA FIXATION DES MEDICAMENTS AUX PROTEINESGUGLER R; SHOEMAN DW; AZARNOFF DL et al.1974; PHARMACOLOGY; SWITZ.; DA. 1974; VOL. 12; NO 3; PP. 160-165; BIBL. 15REF.Article

Hemmung der Mikrosomalen Enzymaktivität der Leber durch unterschiedliche H₂-Rezeptorantagonisten = Inhibition de l'activité enzymatique des microsomes du foie par différents antagonistes des récepteurs-H₂ = Inhibition of hiver microsomal enzyme activity by different H₂-receptor antagonistsJENSEN, J. C; GUGLER, R.Zeitschrift für Gastroenterologie. 1987, Vol 25, Num 2, pp 112-118, issn 0044-2771Article

CIMETIDINE PLASMA CONCENTRATION-RESPONSE RELATIONSHIPSGUGLER R; FUCHS G; DIECKMANN M et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 29; NO 6; PP. 744-748; BIBL. 14 REF.Article

NACHTABFALL DES CARBAMAZEPIN-SERUMSPIEGELS = CHUTE NOCTURNE DU TAUX SERIQUE DE CARBAMAZEPINEFROESCHER W; EICHELBAUM M; GUGLER R et al.1979; NERVENARZT; DEU; DA. 1979; VOL. 50; NO 3; PP. 171-178; BIBL. 38 REF.Article

THE BIOAVAILABILITY OF PHENYTOIN.GUGLER R; FROSCHER W; EICHELBAUM M et al.1977; J. NEUROL.; GERM.; DA. 1977; VOL. 216; NO 3; PP. 155-162; ABS. ALLEM.; BIBL. 27 REF.Article

PHARMACOKINETICS OF PRACTOLOL IN RENAL FAILURE = PHARMACOCINETIQUE DU PRACTOLOL DANS L'INSUFFISANCE RENALEBODEM G; GRIESER H; EICHELBAUM M et al.1974; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1974; VOL. 7; NO 4; PP. 249-252; BIBL. 19REF.Article

Single- and multiple-dose metronidazole kineticsJENSEN, J. C; GUGLER, R.Clinical pharmacology and therapeutics. 1983, Vol 34, Num 4, pp 481-487, issn 0009-9236Article